最近,丹麦哥本哈根大学化学家Jrn Bolstad Christensen的一项研究表明可以使多重耐药细菌对耐受的抗生素再次产生响应,该研究已获得美国专利。Jrn和他的同事希望他们的研究可以很快应用到多重耐药结核病(MDR-TB)的治疗上。结核杆菌是人体中凶残的杀手,抗生素出现使人们看到战胜结核病的曙光,但随着MDR-TB的出现,结核病治疗策略的研究又重新成为全球医药卫生研究人员所面临的一个重大难题。 A recent study by chemist Jrn Bolstad Christensen at the University of Copenhagen in Denmark showed that multiple antibiotic resistant bacteria can once again respond to resistant antibiotics, a study that has been patented in the United States. Jörn and his colleagues hope their research will soon be applied to the treatment of multidrug-resistant tuberculosis (MDR-TB). Mycobacterium tuberculosis is the cruel killer in the human body. The emergence of antibiotics makes people see the dawn of fighting tuberculosis. However, with the advent of MDR-TB, the research on TB treatment strategy has once again become a major challenge for medical and health researchers worldwide.